|
FY2025
12 months to Dec 31, 2025
|
FY2024
11 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Payment of operating costs in exchange for issuance of Founder Shares | ||
| Payment of operating costs through advance from related party | ||
| Interest earned on cash held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Due to Sponsor | ||
| Accrued expenses | ||
| Net cash used in operating activities | ||
| Investment of cash in Trust Account | ||
| Cash withdrawn from Trust Account in connection with redemption | ||
| Net cash provided by (used in) investing activities | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Proceeds from sale of Private Placement Units | ||
| Proceeds from sale of Representative shares | ||
| Advances from related party | ||
| Payment of offering costs | ||
| Proceeds for extension deposit | ||
| Redemption of ordinary shares | ||
| Net cash (used in) provided by financing activities | ||
| Net Change in Cash | ||
| Cash – Beginning of period | ||
| Cash – End of period | ||
| Non-Cash investing and financing activities: | ||
| Accretion of ordinary shares subject to possible redemption value | ||
| Remeasurement of ordinary shares subject to possible redemption value | ||
| Deferred underwriting fee payable | ||
| Offering cost included in advances from related party | ||
| Contributions of extension fees |
Loading...
